Healthcare provider profile · identity verified

Terry A Smith, D.O.

Internal Medicine · POLSON, MT · NPI 1285740290

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	320	67
Losartan Potassium	Losartan Potassium	279	73
Amlodipine Besylate	Amlodipine Besylate	260	64
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	255	40
Omeprazole	Omeprazole	254	59
Gabapentin	Gabapentin	221	55
Metoprolol Succinate	Metoprolol Succinate	208	52
Atorvastatin Calcium	Atorvastatin Calcium	191	54
Tamsulosin Hcl	Tamsulosin Hcl	179	41
Lisinopril	Lisinopril	165	45
Metformin Hcl	Metformin Hcl	147	32
Famotidine	Famotidine	142	43
Trazodone Hcl	Trazodone Hcl	126	25
Meloxicam	Meloxicam	122	22
Furosemide	Furosemide	116	20
Potassium Chloride	Potassium Chloride	103	18
Simvastatin	Simvastatin	102	24
Oxycodone Hcl	Oxycodone Hcl	101	16
Tramadol Hcl	Tramadol Hcl	101	16
Fluoxetine Hcl	Fluoxetine Hcl	98	20
Morphine Sulfate Er	Morphine Sulfate	96	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	95	28
Escitalopram Oxalate	Escitalopram Oxalate	93	20
Hydrochlorothiazide	Hydrochlorothiazide	88	27
Clonazepam	Clonazepam	85	suppressed
Celecoxib	Celecoxib	84	14
Ozempic	Semaglutide	82	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	81	12
Zolpidem Tartrate	Zolpidem Tartrate	81	16
Lorazepam	Lorazepam	73	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	72	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	70	23
Alprazolam	Alprazolam	63	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	61	13
Sertraline Hcl	Sertraline Hcl	61	15
Metoprolol Tartrate	Metoprolol Tartrate	55	12
Duloxetine Hcl	Duloxetine Hcl	52	11
Eliquis	Apixaban	51	suppressed
Warfarin Sodium	Warfarin Sodium	51	suppressed
Peg-3350 And Electrolytes	Peg3350/Sod Sulf,bicarb,cl/Kcl	49	49
Metformin Hcl Er	Metformin Hcl	47	16
Montelukast Sodium	Montelukast Sodium	46	suppressed
Januvia	Sitagliptin Phosphate	43	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	43	24
Citalopram Hbr	Citalopram Hydrobromide	42	12
Glipizide	Glipizide	42	11
Carvedilol	Carvedilol	40	11
Mirtazapine	Mirtazapine	40	suppressed
Allopurinol	Allopurinol	39	suppressed
Promethazine Hcl	Promethazine Hcl	38	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	37	suppressed
Jardiance	Empagliflozin	37	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	35	suppressed
Sucralfate	Sucralfate	35	11
Ventolin Hfa	Albuterol Sulfate	34	suppressed
Bupropion Xl	Bupropion Hcl	33	suppressed
Temazepam	Temazepam	33	suppressed
Gavilyte-G	Peg3350/Sod Sulf,bicarb,cl/Kcl	32	32
Sumatriptan Succinate	Sumatriptan Succinate	32	suppressed
Estradiol	Estradiol	29	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Doxepin Hcl	Doxepin Hcl	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Clopidogrel	Clopidogrel Bisulfate	25	suppressed
Prednisone	Prednisone	24	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Sod Sulf-Potass Sulf-Mag Sulf	Sodium, Potassium,mag Sulfates	21	21
Methocarbamol	Methocarbamol	20	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	20	suppressed
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Baclofen	Baclofen	19	suppressed
Glipizide Er	Glipizide	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Topiramate	Topiramate	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Methadone Hcl	Methadone Hcl	17	suppressed
Olanzapine	Olanzapine	17	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Finasteride	Finasteride	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Diazepam	Diazepam	15	suppressed
Fluticasone Propionate	Fluticasone Propionate	15	suppressed
Glimepiride	Glimepiride	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Metolazone	Metolazone	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Azithromycin	Azithromycin	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Piroxicam	Piroxicam	12	suppressed
Pravastatin Sodium	Pravastatin Sodium	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Atenolol	Atenolol	11	suppressed
Calcitriol	Calcitriol	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	11	suppressed
Rybelsus	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error